Anne co-founded 23andMe in 2006 after a decade spent in healthcare investing, focused primarily on biotechnology companies. Her hope was to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Presently, 23andMe has built one of the world’s largest databases of individual genetic information. Its novel, web-based research approach allows for the rapid recruitment of participants to many genome-wide association studies at once, reducing the time and money needed to make new discoveries, and the company has created a proven and standardized resource for finding new genetic association and confirming genetic loci discovered by others. Under Anne’s leadership 23andMe has made significant advances in bringing personalized medicine directly to the public. Anne graduated from Yale University with a BS in Biology. Getting access to and understanding her own genetic information had always been one of her ambitions.
Andy Page Board Member
Andy Page brings corporate leadership and deep operational expertise to 23andMe. Andy has been a member of the 23andMe board of directors since 2012 and worked as the company president from 2013 until 2016. Before joining 23andMe, Andy served as the president of Gilt Groupe, an online luxury shopping destination, where he oversaw the company’s various businesses and operations including Women’s, Men’s, Kids & Baby, Home, Park & Bond, Gilt City and Gilt Taste. He joined Gilt in April 2010 as the chief financial officer and transitioned to president in 2011. Prior to joining Gilt, Andy was chief operating and financial officer at PlayPhone, Inc., where he was responsible for managing the company’s multinational operations. Before PlayPhone, Andy was chief financial officer and senior vice president of Business Strategy of StubHub Inc. There he managed the company’s financial operations, business strategy, financial reporting, and administrative functions. He led the company’s sale to eBay in 2007. Andy has also held senior executive positions at Panasas Inc., ONI Systems Corp., and Robertson Stephens & Company. Andy holds a BA from Princeton University and a MBA from Harvard Business School. He is an advisor to several private e-commerce companies. He also serves on the board of directors of My New Red Shoes, a nonprofit organization that provides back-to-school clothes for homeless and low-income children in the San Francisco Bay Area.
Esther Dyson, Board Member
Esther Dyson does business as EDventure Holdings, the reclaimed name of the company she owned for 20-odd years before selling it to CNET Networks in 2004. In the last few years, she has turned her sights towards IT and health care. She dedicated two issues of her newsletter, Release 1.0, to the topic (Health and Identity: No Patient Left Behind? in January 2005 and Personal Health Information: Data Comes Alive! in September 2005). Also in September 2005, she ran the Personal Health Information workshop that laid out many of the challenges still perplexing the health-care community. Currently, she is one of the initial ten subjects of George Church’s Personal Genome Project. Her primary activity is investing in start-ups and guiding many of them as a board member. Her board seats include Boxbe, CVO Group (Hungary), Eventful.com, Evernote, IBS Group (Russia, advisory board), Meetup, Midentity (UK), NewspaperDirect, and WPP Group and Yandex (Russia). Some of her past direct IT investments include Flickr, Del.icio.us, BrightMail, Medstory and Orbitz. Dyson was the founding chairman of ICANN from 1998 to 2000, and was also chairman of the Electronic Frontier Foundation in the 90’s. In 1997, she wrote Release 2.0: A Design for Living in the Digital Age, which appeared in paperback a year later as Release 2.1. In 1994, she wrote a seminal essay on intellectual property for Wired magazine.
Patrick Chung, Board Member
Patrick is a founding partner of Xfund. Prior to joining Xfund full-time, Patrick was a partner at NEA and led the firm’s consumer and seed investment practices. He is a director of 23andMe, Curalate, Euclid, MeCommerce, Philo, and Ravel Law, and is actively involved with CrowdMed, Guideline, IFTTT, Landit, Rock Health, Upworthy, and Zumper. Past investments include Pulse (acquired by LinkedIn), Loopt (acquired by Green Dot), GoodGuide (acquired by Underwriters Laboratories), Xfire (acquired by Viacom), and Xoom (NASDAQ: XOOM). Prior to joining NEA, Patrick helped to grow ZEFER, an Internet services firm (acquired by NEC) to more than $100 million in annual revenues and more than 700 people across six global offices. Prior to ZEFER, Patrick was with McKinsey & Company, where he specialized in hardware, software, and services companies. Patrick received a joint JD-MBA degree from Harvard Business School and Harvard Law School, where he served as an Editor of the Harvard Law Review. Patrick was a Commonwealth Scholar at Oxford University, where he earned a Master of Science degree. Patrick earned his A.B. degree at Harvard College in Environmental Science. He is a member of the New York and Massachusetts bars, an elected director of the Harvard Alumni Association, and a member of the Committee to Visit Harvard College.